Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
USP31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCDC154 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3H14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKACA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060604 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZBTB8OS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GLI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNL3L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP9X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on